CIA
ANGO icon

Concurrent Investment Advisors’s AngioDynamics ANGO Stock Holding History

Concurrent Investment Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
19,024
-2,653
-12% -$30.2K ﹤0.01% 1812
2026
Q1 		$246K Buy
21,677
+15
+0.1% +$163 ﹤0.01% 1617
2025
Q4 		$278K Sell
21,662
-7,841
-27% -$96.8K ﹤0.01% 1448
2025
Q3 		$330K Hold
29,503
– – 0.01% 1112
2025
Q2 		$293K Hold
29,503
– – 0.01% 1073
2025
Q1 		$277K Hold
29,503
– – 0.01% 969
2024
Q4 		$270K Hold
29,503
– – 0.01% 871
2024
Q3 		$230K Hold
29,503
– – 0.01% 885
2024
Q2 		$178K Buy
29,503
+17,803
+152% +$110K 0.01% 889
2024
Q1 		$68.7K Hold
11,700
– – ﹤0.01% 869
2023
Q4 		$91.7K Buy
+11,700
New +$81.2K ﹤0.01% 819

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Concurrent Investment Advisors's ANGO Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its AngioDynamics (ANGO) stake by 12% in Q2 2026, selling an estimated $30.2K and leaving 19,024 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Concurrent Investment Advisors first reported a position in ANGO in Q4 2023 and has held it in 11 quarters since. The position peaked at $330K in Q3 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Concurrent Investment Advisors held 19,024 shares of AngioDynamics worth $248K as of Q2 2026.
  • Concurrent Investment Advisors sold 2,653 AngioDynamics shares in Q2 2026, an estimated $30.2K.
  • AngioDynamics made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1812 holding.
  • Concurrent Investment Advisors first reported a position in AngioDynamics in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's AngioDynamics position peaked at $330K in Q3 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.